Pathogenesis of NUT Midline Carcinoma
- 28 February 2012
- journal article
- review article
- Published by Annual Reviews in Annual Review Of Pathology-Mechanisms Of Disease
- Vol. 7 (1), 247-265
- https://doi.org/10.1146/annurev-pathol-011811-132438
Abstract
NUT midline carcinoma (NMC), an aggressive form of squamous cell carcinoma, is defined by the presence of acquired chromosomal rearrangements involving NUT, usually BRD4-NUT fusion genes and, less commonly, NUT-variant fusion genes involving BRD3 or still-uncharacterized genes. Improved diagnostic tests reveal that although rare, NMCs occur in people of any age and may be indistinguishable from more common squamous cell carcinomas of adulthood. NMCs have simple karyotypes whose hallmark is genomic instability, suggesting that NMC arises through a distinct pathogenic pathway representing a genetic shortcut to the phenotype of squamous cell carcinoma. Mechanistically, BRD-NUT fusion proteins appear to act by blocking differentiation, possibly by sequestering histone acetyltransferase activity. Accordingly, histone deacetylase inhibitors or BET inhibitors, the latter of which inhibit binding of BRD-NUT proteins to chromatin, induce terminal differentiation of NMC cells. These insights provide a rationale for targeted therapy of NMC, which is almost uniformly refractory to conventional chemotherapy and radiotherapy.Keywords
This publication has 54 references indexed in Scilit:
- Selective inhibition of BET bromodomainsNature, 2010
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanomaNature, 2010
- Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domainsThe EMBO Journal, 2010
- NUT Gene Rearrangement in a Poorly-differentiated Carcinoma of the Submandibular GlandHead and Neck Pathology, 2010
- Diagnosis of NUT Midline Carcinoma Using a NUT-specific Monoclonal AntibodyThe American Journal of Surgical Pathology, 2009
- Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemiaProceedings of the National Academy of Sciences of the United States of America, 2009
- The Bromodomain Protein Brd4 Stimulates G1 Gene Transcription and Promotes Progression to S PhasePublished by Elsevier BV ,2008
- Human cancers express a mutator phenotypeProceedings of the National Academy of Sciences of the United States of America, 2006
- Complex networks orchestrate epithelial–mesenchymal transitionsNature Reviews Molecular Cell Biology, 2006
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997